|
| UNC2881 Basic information |
Product Name: | UNC2881 | Synonyms: | 2-(Butylamino)-4-[(trans-4-hydroxycyclohexyl)amino]-N-[[4-(1H-imidazol-1-yl)phenyl]methyl]-5-pyrimidinecarboxamide;UNC2881;N-(4-(1H-iMidazol-1-yl)benzyl)-2-(butylaMino)-4-(((1r,4r)-4-hydroxycyclohexyl)aMino)pyriMidine-5-carboxaMide;N-(4-(1H-imidazol-1-yl)benzyl)-2-(butylamino)-4-((1r,4r)-4-hydroxycyclohexylamino)pyrimidine-5-carboxamide UNC2881;N-(4-(1H-Imidazol-1-yl)benzyl)-2-(butylamino)-4-(((1r,4r)-4-hydroxycyclohexyl)amino)pyrimidine;110849;UNC 2881; UNC-2881;CS-1177 | CAS: | 1493764-08-1 | MF: | C25H33N7O2 | MW: | 463.58 | EINECS: | | Product Categories: | Inhibitors | Mol File: | 1493764-08-1.mol | |
| UNC2881 Chemical Properties |
density | 1.31±0.1 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | insoluble in H2O; insoluble in EtOH; ≥13.55 mg/mL in DMSO | form | solid | pka | 12.70±0.46(Predicted) |
| UNC2881 Usage And Synthesis |
Description | UNC2881 is an inhibitor of Mer (IC50 = 4.3 nM), a member of the TAM family of receptor tyrosine kinases. It is selective for Mer over the remaining TAM family members Axl and TYRO3 (IC50s = 360 and 250 nM, respectively). UNC2881 inhibits phosphorylation of Mer in 697 B-ALL acute lymphoblastic leukemia cells (IC50 = 21.9 nM). It inhibits platelet aggregation and ATP release induced by type I equine fibrillar collagen in isolated human platelet-rich plasma when used at a concentration of 3 μM. | Uses | UNC2881 is a specific Mer tyrosine kinase inhibitor. It inhibits collagen-stimulated platelet aggregation. | target | Mer tyrosine kinase | storage | Store at +4°C | references | [1]. zhang w, mciver al, stashko ma, et al. discovery of mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis. j med chem, 2013, 56(23): 9693-9700. |
| UNC2881 Preparation Products And Raw materials |
|